|
|
|
|
LEADER |
00000cam a22000007i 4500 |
001 |
SCIDIR_on1395133727 |
003 |
OCoLC |
005 |
20231120010752.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
230828t20232023enk ob 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e rda
|c YDX
|d OPELS
|d UKMGB
|d YDX
|d VRC
|
015 |
|
|
|a GBC376455
|2 bnb
|
016 |
7 |
|
|a 021026875
|2 Uk
|
020 |
|
|
|a 9780323993814
|q electronic book
|
020 |
|
|
|a 0323993818
|q electronic book
|
020 |
|
|
|z 9780323991384
|
020 |
|
|
|z 0323991386
|
035 |
|
|
|a (OCoLC)1395133727
|
050 |
|
4 |
|a RC953.7
|b .E55 2023eb
|
082 |
0 |
4 |
|a 615.580846
|2 23/eng/20230914
|
100 |
1 |
|
|a Elbeddini, Ali,
|e author.
|
245 |
1 |
0 |
|a Deprescribing and polypharmacy in an aging population /
|c Ali Albeddini.
|
264 |
|
1 |
|a London ;
|a San Diego, CA :
|b Academic Press, an imprint of Elsevier,
|c [2023]
|
264 |
|
4 |
|c �2023
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Chapter 1 A global overview of the current state of deprescribing -- Chapter 2 Health policies and deprescribing: An introduction to health policies, knowledge translation, and the barriers, challenges, and enablers to health policy implementation -- Chapter 3 Deprescribing is an essential part of prescribing -- Chapter 4 Deprescribing in school curriculums: An overview of current education standards and what should be changed -- Chapter 5 The role of the multidisciplinary healthcare team in deprescribing -- Chapter 6 Looking to the future: Artificial intelligence in enhancing patient care* -- Chapter 7 Challenges/barriers of deprescribing during COVID-19 -- Chapter 8 Depre scribing in palliative care and Alzheimer's patients: Optimizing medication use for improved quality of life.
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a "Deprescribing and Polypharmacy in an Aging Population supports healthcare professionals across global healthcare institutions in reducing polypharmacy-related drug replated problems (DRPs) by working with patients, families, interprofessional healthcare professionals, and educational institutions to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety. Polypharmacy, the use of multiple medications at the same time by one person, is very common in various patient populations, including those who lack primary physicians, patients with mental health conditions, patients with multiple chronic conditions, and in the aging population."--publisher website.
|
588 |
|
|
|a Description based on online resource; title from digital title page (viewed on October 25, 2023).
|
650 |
|
0 |
|a Polypharmacy.
|
650 |
|
0 |
|a Older people
|x Drug use.
|
650 |
|
0 |
|a Population aging
|x Health aspects.
|
650 |
|
2 |
|a Polypharmacy
|0 (DNLM)D019338
|
650 |
|
2 |
|a Drug Therapy.
|
650 |
|
2 |
|a Aged.
|
776 |
0 |
8 |
|i ebook version :
|z 9780323993814
|
776 |
0 |
8 |
|c Original
|z 0323991386
|z 9780323991384
|w (OCoLC)1348633918
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323991384
|z Texto completo
|